SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

10/8/24 6:14:57 AM ET

Retail-Drug Stores and Proprietary Stores

Consumer Staples

Get the next $GRDN alert in real time by email

SC 13G 1 guardianpharma13g.txt SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) Guardian Pharmacy Services, Inc. (Name of Issuer) Class A Ordinary shares (Title of Class of Securities) 40145W101 (CUSIP Number) September 26, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ X ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person?s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ? CUSIP No. 40145W101 13G Page 2 of 8 Pages 1. NAMES OF REPORTING PERSONS OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Ophir Global Opportunities Fund 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Australia NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 559,636 Class A Ordinary Shares 6. SHARED VOTING POWER 7. SOLE DISPOSITIVE POWER 559,636 Class A Ordinary Shares 8. SHARED DISPOSITIVE POWER 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 559,636 Class A Ordinary Shares 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.99% 12. TYPE OF REPORTING PERSON (see instructions) OO ? CUSIP No. 40145W101 13G Page 3 of 8 Pages Item 1. (a) Name of Issuer Guardian Pharmacy Services, Inc. (b) Address of Issuer?s Principal Executive Offices 300 Galleria Parkway SE, Suite 800 Atlanta, GA 30339 Item 2. (a) Name of Person Filing Ophir Global Opportunities Fund (b) The address of the principal place of the Filer is located at: Level 27, Governor Philip Tower One Farrer Place, Sydney, NSW 2000 (c) For citizenship of Filers, see Item 4 of the cover sheet for each Filer. Ophir Funds are Australian-domiciled. (d) Title of Class of Securities Class A Ordinary Shares, par value $0.0001 per share (the ?Class A Ordinary Shares?) (e) CUSIP Number 40145W101 Item 3. If this statement is filed pursuant to ??240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [X] An investment adviser in accordance with ?240.13d- 1(b)(1)(ii)(E); CUSIP No. 40145W101 13G Page 4 of 8 Pages (g) [ ] A parent holding company or control person in accordance with ?240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with ?240.13d-1(b)(1)(ii)(J). ? CUSIP No. 40145W101 13G Page 5 of 8 Pages Item 4. Ownership. (a) Amount beneficially owned: 559,636 Class A Ordinary Shares* (b) Percent of class: 6.99% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 559,636 Class A Ordinary Shares* (ii) Shared power to vote or to direct the vote (iii) Sole power to dispose or to direct the disposition of 559,636 Class A Ordinary Shares* (iv) Shared power to dispose or to direct the disposition of * Ophir Asset Management US LLC serves as the investment manager to Ophir Global Opportunities Fund, Ophir Global High Conviction Fund, collectively the ?Ophir Funds? and the Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the Shares for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of the Reporting Person?s pecuniary interest therein. The percentages herein are calculated based upon a statement in the Issuer?s Form 8-K, of September 25, 2024 which was filed on September 30, 2024, that there were 8,000,000 shares of Class A common stock issued and outstanding. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. CUSIP No. 40145W101 13G Page 6 of 8 Pages Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. ? CUSIP No. 40145W101 13G Page 7 of 8 Pages Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: October 2, 2024 Ophir Asset Management US LLC By: /s/ Sandra Donnarumma, CCO ________________________________________ ? CUSIP No. 40145W101 13G Page 8 of 8 Pages EXHIBIT A AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G Statement Pursuant to Rule 13d-1(k)(1) The undersigned hereby consent and agree to file a joint statement on Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Class A Ordinary Shares of Guardian Pharamacy Service, Inc. beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent this Statement pursuant to Rule 13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule 13G. Dated: October 2, 2024 Ophir Asset Management US LLC By: /s/ Sandra Donnarumma, CCO ________________________________________

Get the next $GRDN alert in real time by email

Date

Price Target

Rating

Analyst

10/21/2024

$21.00

Outperform

Raymond James

10/21/2024

$22.00

Buy

Truist

SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

Chat with this insight

Recent Analyst Ratings for
$GRDN

$GRDN
Press Releases

Fastest customizable press release news feed in the world

Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call

Guardian Pharmacy Services Opens New Columbus, Ohio, Location, Strengthening Long-Term Care Presence in Ohio, Kentucky and West Virginia

Guardian Pharmacy Services Adds Naples Pharmacy to Further Strengthen Long-Term Care Services in Southwest Florida

$GRDN
Leadership Updates

Live Leadership Updates

Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy

$GRDN
SEC Filings

Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

SEC Form 8-K filed by Guardian Pharmacy Services Inc.

SEC Form DEFA14A filed by Guardian Pharmacy Services Inc.

$GRDN
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Raymond James initiated coverage on Guardian Pharmacy Services with a new price target

Truist initiated coverage on Guardian Pharmacy Services with a new price target

$GRDN
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Bindley William E converted options into 6,100,176 shares (SEC Form 4)

Officer Morris David K converted options into 641,869 shares, increasing direct ownership by 6,181% to 652,254 units (SEC Form 4)

Officer Burke Fred converted options into 1,298,826 shares (SEC Form 4)

$GRDN
Financials

Live finance-specific insights

Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call

Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call

$GRDN
Large Ownership Changes

This live feed shows all institutional transactions in real time.